Ref No: RK20031210/1731 - Karnataka eoi empanelment drugs 42... · Web viewThe empanelled suppliers...

GOVERNMENT OF KARNATAKA

DEPARTMENT OF HEALTH & FAMILY WELFAREKARNATAKA STATE DRUG LOGISTICS & WAREHOUSING SOCIETY

Expression of Interest for Empanelment of Suppliers

for Drugs, Chemicals, Surgicals & Sutures for the Years 2015-2016 & 2016-17

EOI Ref . No. KDL/EOI/EMPANELMENT/DRUGS/42/2014-15

KARNATAKA STATE DRUG LOGISTICS & WAREHOUSING SOCIETY No.1, Dr. Siddaiah Puranik Road, KHB Colony, Magadi Road, Bangalore – 560079

Phone: +91-80-23283218 Fax: +91-80-23281477Email: [email protected]

Website: http://www.kdlws.kar.nic.in/

http://www.kdlws.kar.nic.in/

mailto:[email protected]

Expres s ion o f In t e r e s t f o r Empane lmen t o f Supp l i e r s fo r Drugs , Chemica l s , Su rg i ca l s & Su tu re s

DisclaimerThis Expression of Interest for Empanelment of Suppliers for Drugs, Chemicals, Surgicals and Sutures contains brief information about the complete process for the selection of the Empanelled Suppliers. The purpose of this Document is to provide the bidders with information to assist them in the preparation and submit their response to this Expression of Interest.

The bidders should conduct their own independent assessment, investigations and analysis and should check the reliability, accuracy and completeness of the information at their end before submission of their response to this Expression of Interest. KSDLWS or Government of Karnataka shall incur no liability under any law, statute, rules or regulations as to the accuracy or completeness of this Expression of Interest.

KSDLWS reserves the right to change any or all conditions / information set in this Document by way of revision, deletion, updation or annulment through issuance of appropriate addendum / corrigendum as KSDLWS may deem fit without assigning any reason thereof.

KSDLWS reserves the right to accept or reject any or all applications without giving any reasons thereof. KSDLWS will not entertain or be liable for any claim for costs and expenses in relation to the preparation and submission of response to this Expression of Interest.

AbbreviationsAbbreviation Full Form

EOI Expression of Interest

IFE Invitation for EOI

ITB Instructions to Bidders

KSDLWS Karnataka State Drug Logistics & Warehousing Society

Ref. Reference

KSDLWS Page 2 of 63


TABLE OF CONTENTSINVITATION FOR EOI (IFE)................................................................................................................4EXPRESSION OF INTEREST (EOI) SCHEDULE.........................................................................................5

SECTION 1 – INSTRUCTIONS TO BIDDERS (ITB).........................................................................................6

1. GENERAL..................................................................................................................................71.1. Scope of EOI...............................................................................................................71.2. Eligible Bidders..........................................................................................................71.3. One EOI per Bidder....................................................................................................71.4. Cost of Tendering......................................................................................................7

2. EOI DOCUMENT.......................................................................................................................72.1. Contents of EOI Document.......................................................................................72.2. Clarification of EOI Document.................................................................................72.3. Pre-bid meeting.........................................................................................................8

3. PREPARATION OF EOI...............................................................................................................83.1. Documents comprising the EOI...............................................................................83.2. EOI prices...................................................................................................................83.3. Format and signing of EOI.......................................................................................9

4. SUBMISSION OF EOI.................................................................................................................94.1. Mode of submission of EOI......................................................................................94.2. Deadline for submission of the EOI.........................................................................94.3. Late EOI......................................................................................................................94.4. Modification and Withdrawal of EOI......................................................................9

5. EOI OPENING AND EVALUATION................................................................................................95.1. Opening of EOI of all Bidders and evaluation to determine qualified Bidders . .95.2. Process to be confidential........................................................................................95.3. Clarification of EOI..................................................................................................105.4. Examination of EOI and determination of responsiveness.................................105.5. Correction of errors................................................................................................105.6. Evaluation and comparison of EOI........................................................................10

6. SAMPLE SUBMISSION AND INSPECTION.....................................................................................117. EMPANELMENT OF SUPPLIERS..................................................................................................11

7.1. Frequency of Empanelment...................................................................................117.2. Extension of Empanelment Period........................................................................11

8. CORRUPT AND FRAUDULENT PRACTICES...................................................................................11

SECTION 2 – QUALIFICATION CRITERIA...................................................................................................13

1. QUALIFICATION CRITERIA – APPLICABLE TO ALL BIDDERS..........................................................142. QUALIFICATION CRITERIA – APPLICABLE FOR INDIAN MANUFACTURERS......................................163. QUALIFICATION CRITERIA – APPLICABLE FOR IMPORTER BIDDERS...............................................174. NOTES RELATED TO QUALIFICATION CRITERIA...........................................................................18

SECTION 3 – SCHEDULE OF ITEMS...........................................................................................................19

1. DRUGS...................................................................................................................................202. SURGICALS & SUTURES...........................................................................................................44

SECTION 4 – ANNEXURES......................................................................................................................... 49

ANNEXURE 1 - EOI OFFER FORM.....................................................................................................50ANNEXURE 2 – TURNOVER STATEMENT............................................................................................51ANNEXURE 3 – AFFIDAVIT FORMAT..................................................................................................52ANNEXURE 4 – MARKET STANDING CERTIFICATE...............................................................................53ANNEXURE 5 – PERFORMANCE CERTIFICATE.....................................................................................58ANNEXURE 6 – MANUFACTURING FACILITY DETAILS..........................................................................60ANNEXURE 7 – SAMPLE SUBMISSION FORMAT..................................................................................64ANNEXURE 8 – LIST OF DRUGS & ITEMS SUBMITTED FOR EMPANELMENT..........................................66

KSDLWS Page 3 of 63


Invitation for EOI (IFE)

EOI No KDL/EOI/EMPANELMENT/DRUGS/42/2014-15 Date: 03/03/2015

1) The Additional Director, Karnataka State Drugs Logistics & Warehousing Society (KSDLWS) invites Expression of Interest (EOI) for Empanelment of Suppliers for Drugs, Chemicals, Surgical & Sutures for the years 2015-16 & 2016-17 as follows:

Sl.No. EOI Empanelment Application Fees (Non-Refundable) (Rs.)

1. Empanelment of Suppliers for Drugs, Chemicals, Surgical & Sutures for the years 2015-16 & 2016-17

Rs. 10,000/-

(Rupees Ten Thousand Only)

(To be paid online through NEFT / RTGS, before EOI due date, to the KSDLWS Account at Union Bank of India, Basaveshwaranagar branch, Account# 564802010003539, Account Type – Savings, Beneficiary Name – Additional Director, KSDLWS, Bangalore, IFSC Code – UBIN0556483)

2) EOI procedure as per KTPP Act shall be followed. The EOI are required to submit single cover through e-procurement, containing the response to EOI consisting the details of their capability (as detailed in Section 2). The Bidders are advised to note the minimum qualification criteria specified in Section 2 Qualification Criteria to get empanelment as suppliers of Drugs, Chemicals, Surgicals & Sutures.

3) The empanelled suppliers will only be eligible to participate in the tender for Supply of Drugs, Chemicals, Surgicals & Sutures for the Years 2015-2016 & 2016-17.

4) The bidders are advised to note the qualification criteria specified in Section 2 to qualify for the empanelment.

5) EOI documents may be downloaded from Government of Karnataka e-Procurement website https://eproc.karnataka.gov.in/eportal/index.seam under login for Contractors. The EOI can be downloaded in the portal as per prescribed date and time published in the portal. Only interested bidders who wish to participate should remit online transaction fee for EOI after registering in the portal. The transaction fee is non-refundable if you wish to participate.

6) EOI must be electronically submitted (on-line through internet) within the EOI due date and time. The EOI will be opened at prescribed time and date in the e-procurement portal.

7) Other details can be seen in the EOI document.

KSDLWS Page 4 of 63

https://eproc.karnataka.gov.in/eportal/index.seam


Expression of Interest (EOI) ScheduleEOI Reference No. KDL/EOI/EMPANELMENT/DRUGS/42/2014-15

Commencement of Download of EOI form from website http://eproc.karnataka.gov.in

From 03/03/2015

Pre-Bid Meeting On 10/03/2015 at 11:00 AM

Last Date for Online Queries through e-procurement website

Up to 11/03/2015 at 5:00 PM

Last Date and Time for Uploading of online EOI in e-Procurement website on or before

Up to 02/04/2015 at 5:00 PM

The online EOI will be opened Online by the Authorized Officer on

On 04/04/2015 at 11:00 AM

Original Document Verification From 07/04/2015 at 11:00 AM Till 18/04/2015 5:00 PM

Bidders shall be intimated of their schedule for Original Document Verification through Website


Place of Opening of EOI e-Procurement Website

Address for Communication Karnataka State Drug Logistics & Warehousing Society No.1, Dr. Siddaiah Puranik Road, KHB Colony, Magadi Road, Bangalore – 560079Phone: +91-80-23283218 Fax: +91-80-23281477Email: [email protected] Website: http://www.kdlws.kar.nic.in/

Note:

1) In the event of the specified date of opening of online EOI being declared a holiday for the purchaser, the online EOI shall be opened on the next working day at the same time and venue.

2) Completed EOI shall be uploaded through e-tendering system by the Bidders using their user ID and addressed to the Additional Director in the manner prescribed under Section 1 of EOI Document on or before the last date & time stipulated.

3) Online Queries through e-Procurement Portal will only be accepted. Queries through letters, emails or any other mode will not be accepted.

KSDLWS Page 5 of 63


mailto:[email protected]


http://eproc.karnataka.gov.in/


SECTION 1 – INSTRUCTIONS TO BIDDERS (ITB)

KSDLWS Page 6 of 63


1. General1.1. Scope of EOI

1.1.1. The Additional Director, KSDLWS invites EOI following Single Cover EOI procedure, from eligible Bidders, for empanelment of Suppliers for Drugs, Chemicals, Surgicals & Sutures detailed in the Table given in the Invitation for EOI (IFT). The Bidders may submit EOI for the EOI detailed in the table given in IFT.

1.1.2. The bidders can submit EOI for one or more than one items.

1.2. Eligible Bidders1.2.1. Bidder should be an Indian manufacturer / importer of drugs,

chemicals, surgicals & sutures.

1.2.2. Bidder shall not be under a declaration of ineligibility for corrupt and fraudulent practices issued by the Government of Karnataka.

1.2.3. EOI from Joint ventures are not acceptable.

1.3. One EOI per Bidder1.3.1. Each bidder shall submit only one EOI for one package. A bidder

who submits or participates in more than one EOI will cause all the proposals with the Bidder’s participation to be disqualified.

1.4. Cost of Tendering1.4.1. The bidder shall bear all costs associated with the preparation and

submission of his EOI, and the Purchaser will in no case be responsible and liable for those costs.

2. EOI Document2.1. Contents of EOI Document

2.1.1. The EOI document consists of the following main sections:

2.1.1.1. Instructions To Bidders (ITB)

2.1.1.2. Qualification Criteria

2.1.1.3. Schedule of Items

2.1.1.4. Annexures

2.2. Clarification of EOI Document2.2.1. A prospective bidder requiring any clarification of the EOI

documents may notify the Purchaser in writing through e-procurement portal up till the date mentioned in the EOI Schedule. The Purchase may respond to any request for clarification earlier than 15 days prior to the deadline for submission of EOI in the form of Corrigendum / Addendum through e-procurement portal only.

KSDLWS Page 7 of 63


2.2.2. Any Corrigendum / addendum thus issued shall be part of the EOI document.

2.3. Pre-bid meeting2.3.1. The bidder or his authorized representative is invited to attend the

pre-bid meeting which will take place at the office of Additional Director, KSDLWS on the day as mentioned in EOI Schedule.

2.3.2. The purpose of the meeting will be to clarify issues and to answer questions on any matter that may be raised at that stage.

2.3.3. The bidder is requested to submit any questions in writing through e-procurement portal before the date mentioned in the EOI Schedule.

2.3.4. Minutes of the meeting, including the text of the questions raised (without identifying the source of enquiry) and the responses given will be published in the form of Corrigendum / Addendum through e-procurement portal only. Any modification of the EOI documents which may become necessary as a result of the pre-bid meeting shall be made by the Purchaser exclusively through the issue of a Corrigendum / Addendum and not through the minutes of the pre-bid meeting.

2.3.5. Non-attendance at the pre-bid meeting will not be a cause for disqualification of a bidder.

3. Preparation of EOI3.1. Documents comprising the EOI

3.1.1. The EOI submitted by the Bidder shall be in single covers and shall contain the documents as follows:

3.1.1.1. Qualification Criteria Documents and other documents as mentioned in Section 2 – Qualification Criteria.

3.1.1.2. Any other documents, if any as mentioned in this EOI document. (Bidders should read the EOI document thoroughly and submit all documents and supporting documents asked for in the EOI document)

3.1.2. And any other materials required to be submitted by Bidders in accordance with these instructions.

3.1.3. The Bidders can submit EOI for one or more than one items. The Bidder should submit the EOI for one or more than one items within the same single cover.

3.2. EOI prices3.2.1. No Price and costs related information shall be quoted by the

Bidder in this EOI.

KSDLWS Page 8 of 63


3.3. Format and signing of EOI3.3.1. Bidder shall submit the EOI electronically using Digital Signature

Certificate as prescribed in the e-procurement portal, before the submission date and time published in e-procurement portal.

4. Submission of EOI4.1. Mode of submission of EOI

4.1.1. Bidder shall submit the EOI electronically before the submission date and time published.

4.2. Deadline for submission of the EOI4.2.1. EOI must be submitted online in eProcurement Portal on or before

the submission date and time published in e-procurement portal.

4.2.2. The Purchaser may extend the deadline for submission of EOI by issuing an amendment in accordance with ITB Section 2.2, in which case all rights and obligations of the Purchaser and the Bidders previously subject to the original deadline will then be subject to the new deadline.

4.3. Late EOI4.3.1. In online e-procurement system, you shall not be able to submit the

EOI after the bid submission time and date as the icon or the task in the e-procurement portal will not be available.

4.4. Modification and Withdrawal of EOI4.4.1. Bidders has all the time to modify and correct or upload any

relevant document in the portal till Bid submission date and time, as published in the e-procurement portal.

5. EOI Opening and Evaluation5.1. Opening of EOI of all Bidders and evaluation to determine qualified

Bidders5.1.1. The Purchaser will open the EOI of all the Bidders received (except

those received late or withdrawn), including modifications made pursuant to ITB Section 4.4. In the event of the specified date of EOI opening being declared a holiday for the Purchaser, the EOI will be opened on the next working day.

5.1.2. The Purchaser will evaluate and determine whether each EOI meets the minimum qualification criteria stipulated in Section 2.

5.1.3. The Purchaser will draw out a list of empanelled Bidders.

5.2. Process to be confidential5.2.1. Information relating to the examination, clarification and evaluation

of EOI and recommendations for empanelment shall not be

KSDLWS Page 9 of 63


disclosed to Bidders or any other persons not officially concerned with such process until the empanelled list of Bidders has been announced. In case any Bidder influences the Purchaser's processing of EOI, the Purchaser may rejection his EOI and may also take other actions as deemed necessary.

5.3. Clarification of EOI5.3.1. To assist in the examination, evaluation, and comparison of EOI,

the Purchaser may, at his discretion, ask any Bidder for clarification of his EOI. The request for clarification and the response shall be in writing or by cable.

5.3.2. Subject to ITB Section 2.2, no Bidder shall contact the Purchaser on any matter relating to its EOI from the time of the EOI opening to the time the contract is awarded. If the Bidder wishes to bring additional information to the notice of the Purchaser, it should do so in writing.

5.3.3. If the bidder wants any clarification related to e-Procurement, they may contact e-Procurement Help desk from 9 AM to 9 PM.

5.4. Examination of EOI and determination of responsiveness5.4.1. Prior to the detailed evaluation of EOI, the Purchaser will

determine whether each EOI; (a) has been properly signed; and; (b) is substantially responsive to the requirements of the EOI documents.

5.4.2. A substantially responsive EOI is one which conforms to all the terms, conditions, and specifications of the EOI documents, without material deviation or reservation. A material deviation or reservation is one (a) which affects in any substantial way the scope, quality, or performance of the Works; (b) which limits in any substantial way, inconsistent with the EOI documents, the Purchaser's rights or the Bidder's obligations under the Contract; or (c) whose rectification would affect unfairly the competitive position of other Bidders presenting substantially responsive EOI.

5.4.3. If a EOI is not substantially responsive, it will be rejected by the Purchaser, and may not subsequently be made responsive by correction or withdrawal of the nonconforming deviation or reservation.

5.5. Correction of errors5.5.1. The Purchaser may waive any minor informality or non-conformity

or irregularity in an EOI which does not constitute a material deviation, provided such a waiver does not prejudice or affect the relative ranking of any Bidder.

5.6. Evaluation and comparison of EOI5.6.1. The Purchaser will evaluate and compare only the EOI determined

to be substantially responsive in accordance with ITB Section 5.4.

KSDLWS Page 10 of 63


5.6.2. The Purchaser reserves the right to accept or reject any variation, deviation, or alternative offer. Variations, deviations, and alternative offers and other factors which are in excess of the requirements of the EOI documents or otherwise result in unsolicited benefits for the Purchaser shall not be taken into account in evaluation.

6. Sample Submission and Inspection6.1. The bidder shall submit the samples to the Purchaser as per the quantity

mentioned in the Sample Submission Form enclosed in Annexure 7.

6.2. The specification of the sample submitted by the bidder should be as per the EOI specification. In case of non-compliance with EOI specification, the samples are liable for rejection.

6.3. The samples are exempted from printing the logogram as per the Purchasers logogram specifications.

6.4. All expenses towards the cost of the samples, transportation cost, delivery cost, etc. shall be borne by the bidder.

6.5. The samples submitted by the bidder shall not be returned, irrespective of outcome of the EOI submitted by the bidder.

6.6. It is mandatory for the EOI to qualify in the Sample Inspection qualify for empanelment.

7. Empanelment of Suppliers7.1. Frequency of Empanelment

7.1.1. The EOI for empanelment of suppliers will be invited every quarter, i.e., in the months of March, June, September and December.

7.2. Extension of Empanelment Period7.2.1. The Purchaser may decide to extend the empanelment period by an

additional period of one (1) year or for any other different period as desired by the Purchaser.

8. Corrupt and Fraudulent Practices8.1. The GOK requires that the Bidders, observe the highest standard of ethics

during the empanelment process. In pursuance of this, the Purchaser/GOK:

8.1.1. will reject a EOI if it determines that the Bidder recommended for empanelment has engaged in corrupt or fraudulent practices in competing for the contract in question;

8.1.2. will declare a firm ineligible, either indefinitely or for a stated period of time, to be awarded a GOK contract if it at any time determines that the firm has engaged in corrupt or fraudulent practices in competing for, or in executing, a GOK contract.





SECTION 2 – QUALIFICATION CRITERIA



1. Qualification Criteria – Applicable to All BiddersAll Bidders (Indian Manufacturers as well as Importers of Drugs) should meet the below mentioned qualification criteria:Sl. No.

Qualification Criteria

Details of Qualification Criteria

Documentary Evidence to be submitted

1. Registration in India The Bidder should be incorporated / registered in India.

Certificate of Incorporation for Pvt. Ltd. & Public Ltd.

VAT Registration for Partnership & Proprietorship firms

2. Registered with Income Tax department

The Bidder should be registered with Income Tax department

Company PAN

IT Returns for the Financial Year 2013-14

3. Sales Tax Registration The Bidder should be registered with Commercial Tax department

VAT/Sales Tax Registration Certificate

Latest Sales Tax Clearance Certificate / Latest VAT Returns

4. Turnover The Bidder should have average annual turnover of minimum Rs. 5 Crores for the last three financial years, viz, 2011-12, 2012-13 & 2013-14.

Turnover statement for last 3 financial years certified by Chartered Accountant with CA registration number, as per format enclosed at Annexure 2.

Balance Sheet and Profit & Loss Statement for last 3 financial years certified by Chartered Accountant.

5. Affidavit The Bidder should submit Affidavit on a Rs. 100/- Stamp Paper. The Affidavit should be duly filled, signed and notarized.

Affidavit on Rs. 100/- Stamp Paper duly filled, signed and notarized as per format enclosed at Annexure 3.

6. Market Standing Certificate

The Bidder should submit Market Standing Certificate for the Drugs and Items for which EOI has been submitted.

Market Standing Certificate duly filled, signed and certified by Chartered Accountant as per format enclosed at Annexure 4.



Sl. No.


Details of Qualification Criteria

Documentary Evidence to be submitted

7. Product Permission The Bidder should submit the latest valid Product Permission Certificate issued by the Drug Controller. The Product Permission should be in Generic Drug Name conforming to the requirements in the EOI.

In case Product Permission is under renewal, the Bidder should submit acknowledgement of application submitted for renewal of Product Permission. However, only after receipt of renewed valid Product Permission, the EOI shall be considered for evaluation.

Product Permission valid on the date of submission of EOI in Generic Drug Name.

8. Performance Certificate

The Bidder should submit Performance Certificate issued by Drugs Controller after 01/01/2015. The drugs mentioned in the Performance Certificate should be Generic Drugs as required in this EOI.

Performance Certificate duly filled, signed and sealed by Drugs Controller as per format enclosed in Annexure 5.



2. Qualification Criteria – Applicable for Indian ManufacturersIn case Bidder is an Indian Manufacturer, the Bidder should meet the following qualification criteria in addition to the qualification criteria mentioned in “Section 2 (1. Qualification Criteria – Applicable to All Bidders)” above.Sl. No.


Details of Qualification Criteria Documentary Evidence to be submitted

1. Manufacturing License

The Bidder should have Manufacturing License stating the list of products permitted for manufacturing, issued under the Drugs & Cosmetics Act 1940 and Rules, valid on the EOI submission date.

In case of drugs, the list of products permitted should be in generic names.

In case Manufacturing License is under renewal, the Bidder should submit acknowledgement of application submitted for renewal of Manufacturing License. However, only after receipt of renewed valid Manufacturing License, the EOI shall be considered for evaluation.

Manufacturing License along with list of products permitted for manufacturing, valid on the EOI submission date.

2. Manufacturing Facility

The Bidder should submit details of their Manufacturing Facility. The Manufacturing Facility should be established and in operations in the name of the Bidder.

Manufacturing Facility Details duly filled, signed and sealed by Chartered Accountant as per format enclosed at Annexure 6.



3. Qualification Criteria – Applicable for Importer BiddersIn case Bidder is an Indian Manufacturer, the Bidder should meet the following qualification criteria in addition to the qualification criteria mentioned in “Section 2 (1. 1. Qualification Criteria – Applicable to All Bidders)” above.Sl. No.


Details of Qualification Criteria Documentary Evidence to be submitted

1. Import License The Bidder should submit Import License for the products being imported along with the list of drugs and items.

In case Import License is under renewal, the Bidder should submit acknowledgement of application submitted for renewal of Import License. However, only after receipt of renewed valid Import License, the EOI shall be considered for evaluation.

Import License valid as on date of submission of EOI.

2. Wholesale License

The Bidder should submit Wholesale License for the products being imported and being sold in India.

In case Wholesale License is under renewal, the Bidder should submit acknowledgement of application submitted for renewal of Wholesale License. However, only after receipt of renewed valid Wholesale License, the EOI shall be considered for evaluation.

Wholesale License valid as on date of submission of EOI.



4. Notes related to Qualification Criteria4.1. It is mandatory for the bidders to meet all the qualification criteria

mentioned in Section 2. Failure to qualify in even one of the qualification criteria shall result in disqualification of the EOI.

4.2. The originals of all the documents uploaded under Technical Bid shall be produced for verification within stipulated time after the opening of the Technical Bid, on the intimated date.

4.3. All costs and expenses (including travel, lodging and boarding) for the subject experts designated by the Purchaser for carrying out Factory Visit at the Manufacturing Unit / Warehouses shall be the responsibility of the Bidder.

4.4. The Bidder should separately submit “List of Drugs & Items Submitted for Empanelment”, as per format enclosed at Annexure 8, duly filled and signed by the Bidder.

4.5. Bidders shall be disqualified, if they have:

4.5.1. Made misleading or false representations in the forms, statements and attachments submitted in proof of the qualification requirements; and/or

4.5.2. Record of poor performance such as abandoning the works, not properly completing the contract, inordinate delays in completion, litigation history, or financial failures, etc.



SECTION 3 – SCHEDULE OF ITEMS



1. Drugs

Sl.No.

Drug / Item Dosage Form Strength Unit Pack

1. 5-Fluorouracil Injection 250mg/5ml 1x1Vial

2. Aceclofenac Tablet 100mg 1x10x10

3. Acetazolamide Tablet 250mg 1x10x10

4. Acetyl Salicylic Acid Dispersible Tablet

150mg 1x10x10


350mg 1x10x10


75mg 1x10x10

7. Acetyl Salicylic Acid EC Tablet 150mg 1x10x10

8. Acriflavin+Glycerin Solution NA 1x50ml

9. Actinomycin D Injection 0.5mg 1x1Vial

10. Acyclovir Cream 0.05 1x15g

11. Acyclovir Injection 250mg 1x1Vial

12. Acyclovir Injection 500mg 1x1Vial

13. Acyclovir Ointment 0.05 1x10g

14. Acyclovir Suspension 400mg/5ml 1x60ml

15. Acyclovir Tablet 200mg 1x10x10



18. Adenosine Injection 3mg/ml 1x2ml

19. Adrenaline Bitartrate Injection 1mg/ml 1x1ml

20. Albendazole Suspension 200mg/5ml 1x10ml

21. Albendazole Tablet 400mg 1x10x10

22. Albumin Injection 0.05 1x100ml

23. Albumin Injection 0.2 1x100ml

24. Allopurinol Tablet 100mg 1x10x10

25. Alpha Interferon Injection 3million IU 1x1Vial

26. Alprazolam Tablet 0.25mg 1x10x10

27. Alprazolam Tablet 0.5mg 1x10x10

28. Ambroxol Syrup 30mg/5ml 1x100ml

29. Amikacin Injection 100mg/2ml 1X1Vial



Sl.No.




32. Amiodarone Tablet 100mg 1x10x10

33. Amiodarone Tablet 200mg 1x10x10

34. Amitriptyline Tablet 25mg 1x10x10

35. Amlodipine Tablet 10mg 1x10x10

36. Amlodipine Tablet 2.5mg 1x10x10

37. Amlodipine Tablet 5mg 1x10x10

38. Amoxycillin Capsule 500mg 1x10x10

39. Amoxycillin Dispersible Tablet

125mg 1x10x10

40. Amoxycillin Powder for suspension

125mg/5ml 1x30ml

41. Amoxycillin Dispersible Tablet

250mg 1x10x10

42. Amoxycillin+Clavulinic acid

Injection 1.2gm 1x1Vial


Injection 600mg 1x1Vial


Powder for suspension

200mg + 28.5mg/5ml 1x30ml


Tablet 625mg 1x10x10

46. Amphotericin B Injection 50mg 1x1Vial

47. Ampicillin Capsule 250mg 1x10x10

48. Ampicillin Capsule 500mg 1x10x10

49. Ampicillin Injection 500mg 1x1Vial

50. Ampicillin Powder for suspension

125mg/5ml 1x40ml

51. Antacid Suspension Activated diamithecon 50mg, Mg(OH)2 250 mg, Dried A(OH)3 250mg, Mg, Al Silicate 50mg) Tablet

1x60ml

52. Anti-D immunoglobin (human)

Injection 300mcg 1x1Vial

53. Antiseptic Handwash - Isopropyl Alcohol

Spray NA 1x100ml

54. Antisnake Venom (Polyvalent Lyophilized)

Powder for Infusion

NA 1x1Vial

55. Antitetanus Human Injection 1,000IU 1x1Vial



Sl.No.


Immunoglobin

56. Antitetanus Human Immunoglobin

Injection 250IU 1x1Vial

57. Antitetanus Human Immunoglobin


58. Artesunate (To be used only in combination with Sulfadoxine +Pyrimethamine)

Tablet 50mg 1x10x10

59. Ascorbic Acid Tablet 100mg 1x10x10

60. Atenolol Tablet 100mg 1x14x10



63. Atorvastatin Tablet 10 mg 1x10x10

64. Atracurium Besilate Injection 10mg/ml 1x1Vial

65. Atropine Sulphate Injection 0.6mg/ml 1x1ml

66. Atropine Sulphate Injection 1mg/ml 1x1ml

67. Atropine Sulphate Ointment 1% 1x5g

68. Azathioprine Tablet 50mg 1x10x10

69. Azithromycin Injection 500mg 1X1Vial

70. Azithromycin Suspension 100mg/5ml 1x10x10

71. Azithromycin Tablet 100mg 1x10x10



74. B.C.G Vaccine Injection NA 1x1Vial

75. Barium Sulphate Suspension 100%w/v 1x1Litre

76. Barium Sulphate Suspension 250%w/v 1x1Litre

77. Beclomethasone Dipropionate

Inhalation 250mcg/dose 1x1

78. Beclomethasone Dipropionate

Inhalation 50mcg/dose 1x1

79. Benzathine Benzyl penicillin

Injection 12lacs 1x1Vial

80. Benzathine Benzyl penicillin


81. Benzoic Acid+Salicylic Acid

Ointment 6%w/w+3%w/w 1x30g

82. Benzoin Compound Tincture As per IP 1x300ml

83. Benzyl benzoate Lotion 25% 1x100ml



Sl.No.


84. Benzyl Penicillin Injection 10lacs 1x1Vial

85. Betamethasone Injection 4mg/ml 1x1Vial

86. Betamethasone Dipropionate

Ointment 0.05%w/w 1x30g

87. Betamethasone Dipropionate

Ointment 0.1%w/w 1x30g

88. Betaxolol Hydrochloride Drops 0.0025 1x5ml

89. Betaxolol Hydrochloride Drops 0.005 1x5ml

90. Bisacodyl Suppository 5mg 1x1

91. Bisacodyl Tablet 5mg 1x10x10

92. Bleaching Powder Powder Contains not less than 30 % w/w of available chlorine (as per I.P)

1x5kg

93. Bleomycin Injection 15mg 1x1Vial

94. Bromhexine Syrup 4mg/5ml 1x100ml

95. Bromocriptine Mesylate Tablet 1.25mg 1x10x10

96. Bromocriptine Mesylate Tablet 2.5mg 1x10x10

97. Budesonide Inhalation 50mcg 1x1

98. Bupivacaine Hydrochloride Injection 0.25%+7.5% Glucose solution

1x20ml

99. Bupivacaine Hydrochloride Injection 0.5%+7.5% Glucose solution

1x20ml

100. Bupivacaine Hydrochloride Injection 0.5% plain 1x20ml

101. Bupivacaine Hydrochloride Injection 5% heavy 1x4ml

102. Busulphan Tablet 2mg 1x10x10

103. Butorphanol Injection 2mg 1x1Vial

104. Calamine Lotion As per IP 1x30ml

105. Calcium carbonate with Vitamin D3

Syrup 125mg/5ml 1x150ml




Tablet 500mg+100IU 1x10x10

108. Calcium Gluconate Injection 100mg/ml 1x10ml

109. Calcium Ipodate Injection 3g 1x1Vial

110. Carbamazepine Syrup 100mg/5ml 1x100ml

111. Carbamazepine Tablet 100mg 1x10x10

112. Carbamazepine Tablet 200mg 1x10x10



Sl.No.


113. Carbimazole Tablet 10mg 1x10x10

114. Carbimazole Tablet 5mg 1x10x10

115. Carboplatin Injection 150mg 1x1Vial

116. Carboplatin Injection 450mg 1x1Vial

117. Carboprost Tromethamine Injection 125mcg 1x1Vial

118. Carvedilol Tablet 3.125mg 1x10x10

119. Cefadroxil Dispersible Tablet

250mg 1x10x10

120. Cefadroxil Syrup 125mg 1x30ml

121. Cefadroxil Tablet 500mg 1x10x10

122. Cefixime Tablet 100mg 1x10x10

123. Cefixime Tablet 200mg 1x10x10

124. Cefotaxime Injection 125mg 1x1Vial

125. Cefotaxime Injection 1g 1x1Vial

126. Cefotaxime Injection 500mg 1x1Vial

127. Cefotaxime with Sterile Water for Injection


128. Ceftazidime Injection 1g 1x1Vial

129. Ceftazidime Injection 250mg 1x1Vial

130. Ceftriaxone Injection 1g 1x1Vial

131. Ceftriaxone Injection 250mg 1x1Vial

132. Cephalexin Capsule 250mg 1x10x10

133. Cephalexin Capsule 500mg 1x10x10

134. Cephalexin Syrup 125mg/5ml 1x30ml

135. Cetrimide Solution 20% (conc. for dilution) 1x500ml

136. Chlorambucil Tablet 2mg 1x10x10

137. Chloramphenicol Eye Drops 0.004 1x5ml

138. Chloramphenicol Eye Drops 0.01 1x5ml

139. Chlorhexidine Solution 5% (conc. for dilution) 1x500ml

140. Chlorhexidine Gluconate + Cetrimide Solution + Isopropyle Alcohol

Solution 7.5%w/v + 15%w/v + 6 to 8%v/v

1x500ml

141. Chloroquine phosphate Injection 40mg/ml 1x1Vial

142. Chloroquine phosphate Syrup 50mg/5ml 1x60ml

143. Chloroquine phosphate Tablet 150mg base 1x10x10

144. Chlorpheniramine Maleate Syrup 0.5mg/5ml 1x60ml



Sl.No.


145. Chlorpheniramine Maleate Tablet 4mg 1x10x10

146. Chlorpromazine Hydrochloride

Injection 25mg/ml 1x2ml




Tablet 50mg 1x10x10

149. Chlortalidone Tablet 12.5mg 1x10x10

150. Chlorthalidone Tablet 6.125mg 1x10x10

151. Cinnarazine Tablet 25mg 1x10x10

152. Ciprofloxacin Hydrochloride

Eye/Ear Drops 0.3%w/v 1x10ml


Injection 200mg/100 ml 1x100ml





156. Cisplatin Injection 10mg 1x1Vial

157. Cisplatin Injection 50mg 1x1Vial

158. Citagliptin Tablet 2mg 1x10x10

159. Citagliptin Tablet 7mg 1x10x10

160. Clindamycin Tablet 150mg 1x10x10

161. Clindamycin Tablet 300mg 1x10x10

162. Clobetasol Propionate + Salicylic Acid

Cream 0.05%+3%w/w 1x30g

163. Clofazimine Capsule 100mg 1x10x10

164. Clofazimine Capsule 50mg 1x10x10

165. Clomiphene citrate Tablet 100mg 1x10x10

166. Clomiphene citrate Tablet 50mg 1x10x10

167. Clomipramine Tablet 50mg 1x10x10

168. Clopidogrel Tablet 75mg 1x10x10

169. Clotrimazole Ear Drops 1%w/v 1x10ml

170. Clotrimazole Gel 2%w/w 1x15g

171. Clotrimazole Pessaries 100mg 1x1

172. Clotrimazole Pessaries 200mg 1x1

173. Clotrimazole (Dusting) Powder 1%w/w 1x30g

174. Clozapine Tablet 100mg 1x10x10



Sl.No.


175. Clozapine Tablet 25mg 1x10x10

176. Condoms NA NA 1x5

177. Co-Trimoxazole (Trimethoprim + Sulphamethoxazole)

Tablet 160+800mg 1x10x10

178. Cryoprecipitate Injection 500IU 1x1

179. Cyanocobalamin Injection 1mg/ml 1x10ml

180. Cyclophosphamide Injection 500mg 1x1Vial

181. Cyclophosphamide Tablet 200mg 1x10x10

182. Cyclophosphamide Tablet 50mg 1x10x10

183. Cyclosporine Capsule 100mg 1x10x10




187. Cyclosporine (Concentrate) Injection 100mg/ml 1x1Vial

188. Cytosine Arabinoside Injection 1000mg 1x1Vial

189. Cytosine Arabinoside Injection 100mg 1x1Vial

190. Cytosine Arabinoside Injection 500mg

191. D.P.T Vaccine Injection NA 1x1Vial

192. Dacarbazine Injection 500mg 1x1Vial

193. Danazol Capsule 100mg 1x10x10

194. Danazol Capsule 50mg 1x10x10

195. Dapsone Tablet 100mg 1x10x10

196. Dapsone Tablet 50mg 1x10x10

197. Daunorubicin Injection 20mg 1x1Vial

198. Desferrioxamine Mesylate Injection 500mg 1x2ml

199. Dexamethasone Injection 4mg/ml 1x2ml

200. Dexamethasone Tablet 0.5mg 1x10x10

201. Dexchlorpheniramine Maleate

Syrup 0.5mg/5ml 1x60ml

202. Dextran-40 Injection 10% 1x500ml

203. Dextran-70 Injection 6% 1x500ml

204. Dextromethorphan Tablet 30mg 1x10x10

205. Dextrose Injection 0.05 1x500ml





Sl.No.




210. Dextrose Injection 25% (25ml) 1x25ml

211. Dextrose with sodium chloride

Infusion 5% + 0.9% 1x500ml

212. Dextrose with Sodium Cloride

Infusion 5% + 0.45% 1x500ml

213. Diazepam Injection 5mg/ml 1x2ml

214. Diazepam Suppository 5mg 1x1

215. Diazepam Syrup 2mg/5ml 1x60ml

216. Diazepam Tablet 2 mg 1x10x10

217. Diazepam Tablet 5mg 1x10x10

218. Diclofenac Injection 25mg/ml 1x3ml

219. Diclofenac Tablet 50mg 1x10x10

220. Diclofenac Topical Form 1% 1x30gm

221. Dicyclomine Hydrochloride Drops 10mg/5ml 1x10ml

222. Dicyclomine Hydrochloride Injection 10mg/ml 1x2ml

223. Dicyclomine Hydrochloride Syrup 10mg/ml 1x30ml

224. Dicyclomine Hydrochloride Tablet 10mg 1x10x10

225. Didanosine Tablet 250mg 1x10x10

226. Didanosine Tablet 400mg 1x10x10

227. Diethylcarbamazine Citrate Tablet 100mg 1x10x10

228. Digoxin Elixir 0.05mg/ml 1x30ml

229. Digoxin Injection 0.25mg/ml 1x2ml

230. Digoxin Tablet 0.25mg 1x10x10

231. Diloxanide Furoate Tablet 500mg 1x10x10

232. Diltiazem Injection 5mg/ml 1x5ml

233. Diltiazem Tablet 30mg 1x10x10

234. Dimercaprol Injection in Oil 50mg/ml 1x2ml

235. Dinoprostone Gel 0.5mg 1x3gm

236. Dithranol Ointment 0.001 1x15g

237. Dithranol Ointment 0.02 1x15g

238. Dobutamine Injection 50mg/ml 1x5ml

239. Domperidone Syrup 1mg/ml 1x30ml

240. Domperidone Tablet 10mg 1x10x10



Sl.No.


241. Dopamine Hydrochloride Injection 40mg/ml 1x5ml

242. Doxorubicin Injection 10mg 1x1Vial

243. Doxorubicin Injection 50mg 1x1Vial

244. Doxycycline Tablet 100mg 1x10x10

245. Efavirenz Capsule 200mg 1x10x10

246. Efavirenz Capsule 600mg 1x10x10

247. EMLA cream (Lidocaine 2.5% and Prilocaine 2.5%)

Cream 2.5%+2.5% 1x5g

248. Enalapril Maleate Injection 1.25mg/ml 1x1ml

249. Enalapril Maleate Tablet 10mg 1x10x10

250. Enalapril Maleate Tablet 2.5mg 1x10x10

251. Enalapril Maleate Tablet 5mg 1x10x10

252. Enoxaparin Injection 40mg 1x1Vial

253. Enoxaparin Injection 60mg 1x1Vial

254. Erythromycin Estolate Syrup 125mg/5ml 1x60ml

255. Erythromycin Estolate Tablet 250mg 1x10x10

256. Erythromycin Estolate Tablet 500mg 1x10x10

257. Escitalopram Tablet 10mg 1x10x10

258. Esmolol Injection 10mg/ml 1x1Vial

259. Ethyl Alcohol Solution 0.7 1x500ml

260. Etoposide Capsule 100mg 1x10x10

261. Etoposide Injection 100mg/5ml 1x1Vial

262. Factor IX Complex (Coagulation Factors II,VII, IX,X)

Injection Dried 1x1Vial

263. Factor VII Injection 1mg/2mg 1x1Vial

264. Factor VIII Concentrate Injection Dried 1x1Vial

265. Fentanyl Injection 50mcg/ml 1x2ml

266. Ferrous Sulphate/ Fumrate Solution 25mg elemental iron (as sulphate)/ml

1x100ml

267. Ferrous Sulphate/Fumrate Tablet Iron equivalent to 100mg elemental iron & folic acid 0.5mg

1x10x10

268. Ferrous Sulphate/Fumrate Tablet Iron equivalent to 20mg elemental iron & folic acid 0.1mg

1x10x10

269. Fluconazole Capsule 100mg 1x10x10




Sl.No.




273. Flumazenil Injection 0.1mg/ml 1x1ml

274. Fluorescein Eye Drops 1% 1x5ml

275. Fluoxetine Injection 25mg 1x20ml

276. Fluoxetine hydrochloride Capsule 20mg 1x10x10

277. Fluphenazine Injection 25mg/ml 1x1ml

278. Flutamide Tablet 250mg 1x10x10

279. Folic Acid Tablet 5mg 1x10x10

280. Folinic Acid Injection 3mg/ml 1x1Vial

281. Formaldehyde Solution Solution Dilute 34 ml of formaldehyde solution with water to produce 100 ml (As per I.P)

1x500ml

282. Fortified Procaine Penicillin


283. Framycetin Sulphate Cream 0.5% 1x15g

284. Fresh frozen plasma Injection NA 1x25ml

285. Furosemide Injection 10mg/ml 1x2ml

286. Furosemide Tablet 40mg 1x10x10

287. Gamma Benzine Hexachloride

Lotion 1%w/v 1x30ml

288. Gemcitabine hydrochloride Injection 1gm 1x1Vial

289. Gemcitabine hydrochloride Injection 200mg 1x1Vial

290. Gentamicin Eye/Ear Drops 0.3% 1x5ml

291. Gentamicin Injection 10mg/ml 1x2ml

292. Gentamicin Injection 40mg/ml 1x10ml

293. Gentian Violet Paint 0.01 1x10ml

294. Glibenclamide Tablet 2.5 mg 1x10x10

295. Glibenclamide Tablet 5mg 1x10x10

296. Glimepiride Tablet 1mg 1x10x10

297. Glimepiride Tablet 2mg 1x10x10

298. Glucagon Injection 1mg/ml 1x1Vial

299. Glutaraldehyde Solution 0.1 1x100ml

300. Glutaraldehyde Solution 2% 1x500ml

301. Glycerin Solution NA 1x500ml



Sl.No.


302. Glyceryl Trinitrate Injection 5mg/ml 1x2ml

303. Glyceryl Trinitrate (Sublingual)

Tablet 0.5mg 1x10x10

304. Glycopyrolate Injection 0.2mg 1x1ml

305. Haemocoagulase aqueous Injection 1 NIH 1x1Vial

306. Haloperidol Injection 5mg/ml 1x1Vial

307. Haloperidol Tablet 5mg 1x10x10

308. Halothane with Vaporizer Inhalation 250ml 1x250ml

309. Heparin Sodium Injection 1,000IU/ml 1x1Vial

310. Heparin Sodium Injection 5,000IU/ml 1x1Vial

311. Hepatitis B Vaccine Injection NA 1x1Vial

312. Homatropine Drops 2% 1x5ml

313. Hydrochlorothiazide Tablet 12.5mg 1x10x10

314. Hydrochlorothiazide Tablet 25mg 1x10x10

315. Hydrocortisone Sodium Succinate

Injection 100mg/ml 1x1Vial





318. Hydrogen Peroxide Solution 6% 1x30ml

319. Hydroxychloroquine Phosphate


320. Hyoscine Butyl Bromide Injection 20mg/ml 1x1ml

321. Hyoscine Butyl Bromide Tablet 10mg 1x10x10

322. Ibuprofen Syrup 100mg/5ml 1x60ml

323. Ibuprofen Tablet 200mg 1x10x10

324. Ibuprofen Tablet 400mg 1x10x10

325. Ifosfamide Injection 1gm/2ml 1x1Vial

326. Imatinib Tablet 100mg 1x10x10

327. Imatinib Tablet 400mg 1x10x10

328. Imipramine Tablet 25mg 1x10x10

329. Imipramine Tablet 75mg 1x10x10

330. Indinavir Capsule 200mg 1x10x10

331. Indinavir Capsule 400mg 1x10x10

332. Insulin Injection (Soluble) (Specification as per NCD)

Injection 40IU/ml 1x10ml



Sl.No.


333. Intermediate Acting(Lente/NPH Insulin)

Injection 40IU/ml 1x10ml

334. Intraperitoneal Dialysis Solution

Solution 4Of approximate composition

1x1000ml

335. Iodine Solution 8mg/5ml 1x5ml

336. Ipratropium bromide Inhalation 20mcg/metered dose 1x1

337. Ipratropium Bromide Inhalation 20mcg/puff 1x200md

338. Iron Dextran Injection 50mg/ml 1x1ml

339. Iron Sucrose Injection 100mg/5ml 1x5ml

340. Isoflurane Inhalation 250ml 1x250ml

341. Isosorbide 5 Mononitrate/ Dinitrate

Tablet 10mg 1x10x10

342. Isosorbide 5 Mononitrate/ Dinitrate

Tablet 20mg 1x10x10

343. Isoxsuprine Injection 5mg/ml 1x2ml

344. Isoxsuprine Tablet 20mg 1x10x10

345. IUD containing Copper IUD NA NA

346. IUD containing

Levo Nargisteron

IUD NA 1x1

347. Ketaconazole Tablet 200mg 1x10x10

348. Ketamine Hydrochloride Injection 10mg/ml 1x10ml

349. Ketamine Hydrochloride Injection 50mg/ml 1x2ml

350. Labetolol Tablet 100mg 1x10x10

351. Lactobacilus Dispersible Tablet

10Million 1x10x10

352. Lamivudine Tablet 150mg 1x10x10

353. Lamivudine + Nevirapine + Stavudine

Tablet 150mg+200mg+30mg 1x10x10

354. Lamivudine + Zidovudine Tablet 150mg+300mg 1x10x10

355. L-Asparaginase Injection 5000 KU 1x1Vial

356. Leflunomide Tablet 10mg 1x10x10

357. Leflunomide Tablet 20mg 1x10x10

358. Levo Cetrizine Tablet 10mg 1x10x10

359. Levodopa+Carbidopa Tablet 100mg+10mg 1x10x10

360. Levodopa+Carbidopa Tablet 100mg+25mg 1x10x10

361. Levofloxacin Tablet 500mg 1x10x10

362. Levofloxacin Tablet 250mg 1x10x10



Sl.No.


363. Levothyroxine Tablet 100mcg 100x1bottle




367. Lignocaine Eye Drops 4% 1x5ml

368. Lignocaine Hydrochloride Injection 0.01 1x30ml



371. Lignocaine Hydrochloride Jelly 2% 1x30gm

372. Lignocaine Hydrochloride Jelly 5% 1x30gm

373. Lignocaine Hydrochloride Spray 0.02 1x100ml

374. Lignocaine Hydrochloride Spray 0.1 1x100ml

375. Lignocaine Hydrochloride Topical Form 0.04 1x20

376. Lignocaine Hydrochloride + Adrenaline

Injection 1%+1:2,00,000 1x30ml


Injection 2%+1:2,00,000 1x30ml


Injection 20mg/ml+0.01mg/ml 1x30ml

379. Lignocaine Hydrochloride + Glucose

Spinal Injection 5%+7.5% 1x2ml

380. Liquid Paraffin Solution 60ml 1x60ml

381. Lithium Carbonate Tablet 300mg 1x10x10

382. Lorazepam Injection 2mg/ml 1x2ml

383. Lorazepam Tablet 1mg 1x10x10

384. Lorazepam Tablet 2mg 1x10x10

385. Losartan Potassium Tablet 25mg 1x10x10

386. Losartan Potassium Tablet 50mg 1x10x10

387. Magnesium sulphate Injection 500mg/ml 1x2ml

388. Mannitol Injection 0.1 1x100ml

389. Mannitol Injection 0.2 1x100ml

390. Measles Vaccine Injection NA 1x1Vial

391. Medroxy Progesterone Acetate

Tablet 10mg 1x10x10

392. Medroxy Progesterone Acetate

Tablet 5mg 1x10x10

393. Mefenamic Acid + Tablet 10mg 1x10x10



Sl.No.


Dicyclomine

394. Mefloquine Tablet 250mg base 1x10x10

395. Meglumine Lothalamate Injection 60%w/v (Iodine =280mg/ml)

1x1Vial

396. Meglumine Lotroxate Solution 5-8 g Iodine in

100-250ml

1x250ml

397. Melphalan Tablet 2mg 1x10x10

398. Melphalan Tablet 5mg 1x10x10

399. Mercaptopurine Injection 100mg/ml 1x1Vial

400. Mercaptopurine Tablet 50mg 1x10x10

401. Mesna Injection 200mg 1x1Vial

402. Metformin Tablet 500mg 1x10x10

403. Methotrexate Injection 50mg/ml 1x1Vial

404. Methotrexate Tablet 10mg 1x10x10

405. Methotrexate Tablet 2.5mg 1x10x10

406. Methotrexate Tablet 5mg 1x10x10

407. Methotrexate Tablet 7.5mg 1x10x10

408. Methyl Cellulose Injection 2% 1x10ml

409. Methyl Ergometrine Injection 0.2mg/ml 1x1Vial

410. Methyl Ergometrine Tablet 0.125mg 1x10x10

411. Methyl Prednisolone Injection 40mg/ml 1x1Vial

412. Methylcobalamin Injection 1500mcg 1x1ml

413. Methylcobalamin Tablet 1500mcg 1x10x10

414. Methyldopa Tablet 250mg 1x10x10

415. Methylrosanilinium Chloride (Gentian Violet)

Aqueous solution

0.5% 1x10ml

416. Methylthioninium Chloride (Methylene Blue)

Injection 10mg/ml 1x10ml

417. Metoclopramide Injection 5mg/ml 1x2ml

418. Metoclopramide Syrup 5mg/5ml 1x30ml

419. Metoclopramide Tablet 10mg 1x10x10

420. Metoprolol Tablet 25mg 1x10x10

421. Metoprolol Tablet 50mg 1x10x10

422. Metronidazole Gel 10mg/gm 1x30g

423. Metronidazole Infusion 500mg/100ml 1x100ml



Sl.No.


424. Metronidazole Syrup 100mg/5ml 1x60ml

425. Metronidazole Syrup 200mg/5ml 1x60ml

426. Metronidazole Tablet 200mg 1x10x10

427. Metronidazole Tablet 400mg 1x10x10

428. Miconazole Eye Drops 1% 1x5ml

429. Miconazole Ointment 0.02 1x15g

430. Midazolam Injection 1mg/ml 1x5ml

431. Midazolam Injection 5mg/ml 1x1ml

432. Mifepristone Tablet 200mg 1x5x10

433. Misoprostol Tablet 100mcg 1x4x10

434. Misoprostol Tablet 200mcg 1x4x10

435. Mitomycin-C Injection 10mg 1x1Vial

436. Montelukast Tablet 10mg 1x10x10

437. Montelukast Tablet 5mg 1x10x10

438. Morphine Sulphate Injection 10mg/ml 1x1ml

439. Morphine Sulphate Tablet 10mg 1x10x10

440. Multiple Electrolytes and Dextrose Inj (Adult)Type III

Injection 500ml 1x500ml

441. Multiple Electrolytes and Dextrose Inj (Paediatric)Type I

Injection 500ml 1x500ml

442. Multivitamins Injection (As per Schedule V of Drugs and Cosmetics Rules)

1x1ml

443. Multivitamins Syrup As per Schedule V of Drugs and Cosmetics Rules

1x200ml

444. Multivitamins Tablet As per Schedule V of Drugs and Cosmetics Rules

1x10x10

445. N/2 Saline Injection 0.0045 1x500ml

446. N-Acetylcysteine Injection 200mg/ml 1x5ml

447. Naloxone Injection 0.4mg/ml 1x2ml

448. Nelfinavir Capsule 250mg 1x10x10

449. Neomycin+Bacitracin Ointment 5mg+500IU/g 1x30g

450. Neostigmine Injection 0.5mg/ml 1x1Vial

451. Neostigmine Tablet 15mg 1x10x10

452. Nevirapine Capsule 200mg 1x10x10



Sl.No.


453. Nevirapine Suspension 50mg/5ml 1x10x10

454. Nicotinamide Tablet 50mg 1x10x10

455. Nifedipine Tablet 10mg 1x10x10

456. Nitrazepam Tablet 5mg 1x10x10

457. Nitrous Oxide Inhalation 10kg Pin Index Type A Cylinder

458. Norethisterone Tablet 5mg 1x10x10

459. Norfloxacin (Film Coated) Tablet 400mg 1x10x10

460. Nystatin Pessaries 1,00,000IU 1x1

461. Nystatin Tablet 5,00,000IU 1x10x10

462. Ofloxacin Eye Drops 3mg/ml 1x10ml

463. Ofloxacin Injection 200mg/100ml 1x100ml

464. Ofloxacin Syrup 50mg/5ml 1x100ml

465. Ofloxacin Tablet 200mg 1x10x10

466. Ofloxacin + dexamethasone phosphate

Eye Drops 0.3 + 0.1%w/v 1x5ml

467. Ofloxacin + Ornidazole Syrup 50mg+125mg/5ml 1x30ml

468. Ofloxacin DT Tablet 100mg 1x10x10

469. Olanzapine Tablet 10mg 1x10x10

470. Olanzapine Tablet 5mg 1x10x10

471. Omeprazole Capsule 20mg 1x10x10

472. Omeprazole Capsule 40mg 1x10x10

473. Ondansetron Injection 2mg/ml 1x2ml

474. Ondansetron Syrup 2mg/ml 1x30ml

475. Ondansetron Tablet 4mg 1x10x10

476. Ondansetron Tablet 8mg 1x10x10

477. Oral Poliomyelitis Vaccine(OPV)

Drops NA 1x1Vial

478. Oral Rehydration Salts Powder for solution

2.6g/L Potassium chloride: 1.5g/L

Trisodium citrate dihydrate + 2.9g/L

Powder for dilution in 200ml; 500 ml;

1000ml. (As per I.P)

1x20.5g

479. Ornidazole Tablet 500mg 1x10x10

480. Oxaliplatin Injection 50mg 1x1Vial



Sl.No.


481. Oxygen Inhalation 10kg Pin Index Type A Cylinder

482. Oxymetazoline (Nasal) Drops 0.5mg/ml 1x10ml

483. Oxytocin Injection 5IU/ml 1x1ml

484. Paclitaxel Injection 30mg/5ml 1x1Vial

485. Pancuronium Injection 2mg/ml 1x2ml

486. Pantoprazole Injection 40mg 1x1Vial

487. Pantoprazole Tablet 40mg 1x10x10

488. Paracetamol Drops 125mg/5ml 1x15ml

489. Paracetamol Infusion 1gm/100ml 1x100ml

490. Paracetamol Infusion 500mg/50ml 1x50ml

491. Paracetamol Injection 150mg/ml 1x2ml

492. Paracetamol Suppository 80mg 1x1

493. Paracetamol Syrup 125mg/5ml 1x60ml

494. Paracetamol Tablet 500mg 1x10x10

495. Paracetamol Tablet 650mg 1x10x10

496. Penicillamine Tablet 250mg 1x10x10

497. Pentavalent Vaccine Injection NA 1x1Vial

498. Pentazocine Injection 30mg/ml 1x1ml

499. Pheniramine Maleate Injection 22.75 mg/ml 1x2ml

500. Phenobarbitone Injection 200mg/ml 1x1Vial

501. Phenobarbitone Syrup 20mg/5ml 1x60ml

502. Phenobarbitone Tablet 30mg 1x10x10

503. Phenobarbitone Tablet 60mg 1x10x10

504. Phenylephrine Drops 5% 1x5ml

505. Phenytoin Sodium Injection 50mg/ml 1x2ml

506. Phenytoin Sodium Suspension 25mg/ml 1x100ml

507. Phenytoin Sodium Tablet 100mg 1x10x10

508. Phytomenadione Injection 10mg/ml 1x1Vial

509. Pilocarpine Drops 0.02 1x5ml

510. Pilocarpine Drops 0.04 1x5ml

511. Pioglitazone Tablet 15mg 1x10x10

512. Piperazine Syrup 750mg/5ml 1x100ml

513. Piperazine Tablet 4.5gm 1x10x10



Sl.No.


514. Piroxicam Dispersible Tablet

50mg 1x10x10

515. Plasma Expander Infusion 0.06 1x500ml

516. Platelet Rich Plasma Injection NA 1x250ml

517. Polygeline Injection 3.5% 1x500ml

518. Potassium Chloride Injection 11.2% Sol. 1x500ml

519. Potassium Permanganate Crystals for solution

450g 1x500g

520. Povidone Iodine Drops 0.6% 1x5ml

521. Povidone Iodine Ointment 5% 1x125g

522. Povidone Iodine Ointment 5% 1X15g

523. Povidone Iodine Solution 0.1 1x500ml

524. Pralidoxime Chloride(2- PAM)

Injection 1g 1x1Vial

525. Pralidoxime Chloride(2- PAM)


526. Praziquantel Tablet 600mg 1x10x10

527. Prednisolone Tablet 10mg 1x10x10



530. Prednisolone (as sodium phosphate or succinate)


531. Prednisolone (as sodium phosphate or succinate)


532. Prednisolone Sodium Phosphate

Eye Drops 1% 1x5ml

533. Premix Insulin 30:70 Injection 40IU/ml 1x10ml

534. Primaquine Tablet 2.5mg 1x10x10

535. Primaquine Tablet 7.5mg 1x10x10

536. Procainamide Hydrochloride


537. Procainamide Hydrochloride


538. Procarbazine Capsule 50mg 1x10x10

539. Promethazine Injection 25mg/ml 1x2ml

540. Promethazine Syrup 5mg/5ml 1x60ml

541. Promethazine Tablet 25mg 1x10x10

542. Propofol Injection 1% oil suspension 1x1Vial



Sl.No.


543. Protamine Sulphate Injection 10mg/ml 1x5ml

544. Prothrombin Complex Concentrate


545. Pyrazinamide Tablet 1000mg 1x10x10




549. Pyridostigmine Injection 1mg/ml 1x1Vial

550. Pyridostigmine Tablet 60mg 1x10x10

551. Pyridoxine Tablet 25mg 1x10x10

552. Pyridoxine Tablet 10mg 1x10x10

553. Pyrimethamine Tablet 25mg 1x10x10

554. Quinine sulphate Injection 300mg/ml 1x1Vial

555. Quinine sulphate Tablet 300mg 1x10x10

556. Rabies Immunoglobin Injection 150 IU/ml 1x1Vial

557. Rabies Vaccine Injection 2.5IU 1x1ml

558. Raloxifene Tablet 60mg 1x10x10

559. Ranitidine Injection 25mg/ml 1x2ml

560. Ranitidine Tablet 150mg 1X10X10

561. Riboflavin Tablet 5mg 1x10x10

562. Rifampicin Tablet 450mg 1x10x10

563. Rifampicin Tablet 50mg 1x10x10

564. Ringer Lactate Injection As per IP 1x500ml

565. Risperiddone Tablet 2mg 1x10x10

566. Risperiddone Tablet 4mg 1x10x10

567. Ritonavir Capsule 100mg 1x10x10

568. Ritonavir Syrup 400mg/5ml 1x60ml

569. Roxithromycin Dispersible Tablet

50mg 1x10x10

570. Roxithromycin Tablet 150mg 1x10x10

571. Salbutamol Inhalation 5mg/ml 1x15ml

572. Salbutamol sulphate Inhalation 100mcg/dose 1x1

573. Salbutamol sulphate Syrup 2mg/5ml 1x100ml

574. Salbutamol sulphate Tablet 2mg 1x10x10

575. Salbutamol sulphate Tablet 4mg 1x10x10



Sl.No.


576. Salicylic Acid Ointment 0.03 1x30g

577. Salicylic Acid Solution 5% 1x100ml

578. Saline for Injection Injection 10ml 1x10ml



581. Saquinavir Capsule 200mg 1x10x10

582. Secnidazole Tablet 1g 1x10x10

583. Serratiopeptidase Tablet 10mg 1x10x10

584. Sertraline Tablet 50mg 1x10x10

585. Sevoflurane Inhalation 250ml 1x250ml

586. Silver Sulphadiazine Cream 1% 1x50g

587. Sodium Bicarbonate Injection As per IP 1x500ml

588. Sodium Chloride Injection 3%w/v 1x500ml

589. Sodium Chloride (Nasal) Drops 0.65%w/v 1x15ml

590. Sodium Chloride (Normal Saline)

Injection 0.9%w/v 1x500ml

591. Sodium hypochlorite solution

NA 0.1 1x1Litre

592. Sodium Lothalamate Injection 70%w/v (Iodine =420 mg/ml)

1x1Vial

593. Sodium Meglumine Diatrizoate

Injection 60%w/v (Iodine conc. =292 mg/ml)

1x1Vial

594. Sodium Meglumine Diatrizoate

Injection 76%w/v (Iodine conc.=370 mg/ml)

1x1Vial

595. Sodium Nitrite Injection 30mg/ml 1x1Vial

596. Sodium Nitroprusside Injection 50mg/5ml 1x5ml

597. Sodium Thiosulphate Injection 250mg/ml 1x2ml

598. Sodium Valproate Injection 100mg/ml 1x2ml

599. Sodium Valproate Syrup 200mg/5ml 1x100ml

600. Sodium Valproate Tablet 200mg 1x10x10

601. Sodium Valproate Tablet 500mg 1x10x10

602. Spironolactone Tablet 25mg 1x10x10

603. Stavudine Capsule 15mg 1x10x10



606. Stavudine+ Lamivudine Tablet 30mg+150mg 1x10x10

607. Streptokinase Injection 15,00,000IU 1x1Vial



Sl.No.


608. Streptokinase Injection 7,50,000IU 1x1Vial

609. Succinyl choline chloride Injection 50mg/ml 1x1Vial

610. Sulfadoxine + Pyrimethamine

Tablet 500mg+25mg 1x10x10

611. Sulfasalazine Tablet 500mg 1x10x10

612. Sulphacetamide Sodium Drops 0.1 1x5ml

613. Sulphadiazine Tablet 500mg 1x10x10

614. Tamoxifen Citrate Tablet 10mg 1x10x10

615. Tamoxifen Citrate Tablet 20mg 1x10x10

616. Telmisartan Tablet 40mg 1x10x10

617. Terbutalin dexamethasone dipropionate

Inhalation 200mcg 1x1ml

618. Tetanus Toxoid Injection 0.5ml 1x1Vial

619. Tetanus Toxoid Injection Multidose 1x1Vial

620. Tetracycline Capsule 500mg 1x10x10

621. Theophylline + Etophylline Injection 50.6mg+169.4mg/2ml 1x2ml

622. Theophylline + Etophylline Syrup 23mg+77mg 1x60ml

623. Theophylline + Etophylline Tablet 23mg+77mg 1x10x10

624. Thiamine Injection 100mg/ml 1x10ml

625. Thiamine Tablet 100mg 1x10x10

626. Thiopentone Sodium Injection (Powder)

1gm 1x1Vial

627. Timolol Maleate Drops 0.0025 1x5ml

628. Timolol Maleate Drops 0.005 1x5ml

629. Tinidazole Infusion 500mg/100ml 1x100ml

630. Tinidazole Tablet 300mg 1x10x10

631. Tinidazole Tablet 500mg 1x10x10

632. Tramadol Capsule 100mg 1x10x10

633. Tramadol Capsule 50mg 1x10x10

634. Tramadol Injection 50mg/ml 1x2ml

635. Tranexamic Acid Injection 100mg/ml 1x1Vial

636. Triamcinolone Injection 10mg/ml 1x10x10

637. Trihexyphenidyl Hydrochloride

Tablet 2mg 1x10x10

638. Tropicamide Eye Drops 0.5% 1x5ml

639. Tropicamide Eye Drops 1% 1x5ml



Sl.No.


640. Tuberculin, Purified Protein derivative

Injection 1TU 1x1Vial

641. Tuberculin, Purified Protein derivative

Injection 5TU 1x1Vial

642. Valathamate Bromide Injection 8mg/ml 1x1ml

643. Vecuronium Injection 2mg/ml 1x1Vial

644. Verapamil Injection 2.5mg/ml 1x1Vial

645. Verapamil Tablet 40mg 1x10x10

646. Verapamil Tablet 80mg 1x10x10

647. Vinblastine sulphate Injection 10mg 1x1Vial

648. Vincristine Injection 1mg/ml 1x1Vial

649. Vitamin A Capsule 50,000IU 1x10x10

650. Vitamin A Injection 50,000IU/ml 1x2ml

651. Vitamin A (Concentrated) Solution 1,00,000IU/ml 1x100ml

652. Vitamin A + D Capsule 6,000IU + 1,000IU 1x10x10

653. Vitamin B Complex Injection As per Schedule V of Drugs and Cosmetics Rules

1x1ml

654. Vitamin B Complex (B1, B6 & B12)

Syrup (As per Schedule V of Drugs and Cosmetics Rules)

1x200ml

655. Vitamin B Complex (Therapeutic)

Tablet As per Schedule V of Drugs and Cosmetics Rules

1x10x10

656. Vitamin C Chewable (Ascorbic Acid)


657. Vitamin D (Ergocalciferol) Capsule 0.25mg in 60,000 Units 1x10x10

658. Warfarin sodium Tablet 5mg 1x10x10

659. Water for Injection Injection 10ml 1x10ml



662. White phenol Solution 5Ltr 1x5Ltr

663. Xylocaine+Glucose Injection 2%+7.5% 1x1ml

664. Zidovudine Tablet 100mg 1x10x10

665. Zidovudine Tablet 300mg 1x10x10

666. Zidovudine+ Lamivudine+ Nevirapine

Tablet 300mg+150mg+ 200mg 1x10x10

667. Zinc Sulfate Syrup 20mg/5ml 1x30ml



2. Surgicals & SuturesSl.No. Item Size Unit Pack

668. Bandage cloth individually packed in poly-pack

20 Mtrs. 1x20mtrs

669. IV Cannula (two way) 20G 1x1

670. Sterile disposable IV cannula with inj port

20G 1x1


22G 1x1


24G 1x1

673. Chromic (CD R B needle 40mm length 75cm)

PLAIN 1x12foils


1 1x12foils


1-0 1x12foils


2-0 1x12foils

677. Folly’s catheters with bulb [sterile] 16F x 30ML 1x1

678. Folly’s catheters with bulb [sterile] 18F x 30ML 1x1

679. Malecots catheter 18G 1x1

680. Suction catheter 6 1x1





685. Absorbent cotton wool 500 GM 1x500gm

686. Corrugated rubber Drain As per Ind std.

687. Endotracheal tubes with cuff [pvc] [sterile]

3 1x1


3.5 1x1


4 1x1


4.5 1x1


5 1x1


5.5 1x1


6 1x1



Sl.No. Item Size Unit Pack


7 1x1


8 1x1

696. Infant feeding tube 5F 1x1



699. ECG Gel 250 ml 1x250ml

700. Ultrasound Gel 250 ml 1x250ml

701. Sterile surgical gloves (latex) 6 1x10pairs

702. Sterile surgical gloves (latex) 7 1x10pairs

703. Sterile surgical gloves (latex) 6 ½ 1x10pairs

704. Sterile surgical gloves (latex) 7½ 1x10pairs

705. Surgical gloves (reusable) 7 1x10pairs

706. Surgical gloves (reusable) 7½ 1x10pairs

707. Surgical gloves (reusable) 6½ 1x10pairs

708. Sterile disposable perfusion (infusion) sets with filter

Adult 1x1

709. Sterile disposable perfusion (infusion) sets with filter

Paediatric 1x1

710. Blood Grouping Kit (AB Grouping 7 RH Typing)

NA

711. Blood Sugar Testing Strip NA 1x50

712. Filter Paper NA

713. HBSAG Kit NA

714. Micro Glass Slide 75mm x 25mm x 1.3mm (±0.2mm)

715. NSI Dengue Antigen Kit Card / Strip / Cassette

716. Rapid Diagnostic Kits for PF Antigen Detection

Card / Strip / Cassette

717. Reagent Sticks for Urine Analysis (Glucose)

NA 1x50

718. Urine Pregnancy Test Kit NA

719. VDRL KIT 100 Test Kit

720. WIDAL KIT NA

721. Plaster of paris bandage 10cmx2.7mts 1x1roll

722. Plaster of paris bandage 15x2.7mts 1x1roll

723. Ryle’s tubes 14F 1x1




Sl.No. Item Size Unit Pack


726. Spinal needle(lumbar puncture) needle disposable,color coded transparent hubce certified

24G 1x1


25G 1x1


26G 1x1

729. Urine collection bag with valve out-let. 1.5litre 1x1

730. Surgical blade 10 1x100





735. Adhesive tape 10cmx10mts 1x3rolls

736. Hypo allergenic tape micropore 7.5cmx9.1mts 1x4rolls

737. Antibacterial coated polyglactine 910 with 1/2 circle round body 30mm suture length 90cm

2-0 1x12foils


1 1x12foils


1-0 1x12foils

740. Monofilament polypropylene 100cm with curved round body needle size 40mm

1 1x12

741. Poly propylene mesh 10cm x 6cm 1x3

742. Poly propylene mesh 15cm x 15cm 1x3

743. Sterile disposable insulin syringe with needle

26G 1x100

744. Sterile disposable syringe with hypodermic needle

2ml-22G 1x100


2ml-23G 1x100


5ml-22G 1x100


5ml-23G 1x100

748. Blood transfusion set NA 1x1





SECTION 4 – ANNEXURES



Annexure 1 - EOI Offer Form

EOI OFFER FORMIFE No.: __________________________ Date: __/__/2015

To,

Additional Director, Karnataka State Drug Logistic and Ware Housing Society, Siddaiah Puranik Road, Bangalore – 560 079

Sir,

Having examined the Expression of Interest (EOI) document for empanelment of Suppliers for Drugs, Chemicals, Surgicals & Sutures to KSDLWS for the years 2015-16 & 2016-17 called by you, I / We hereby submit our Expression of Interest for empanelment for the drugs and items selected in the “Annexure 8 – List of Drugs & Items” in conformity with the terms and conditions of the EOI.

Date: Signature of Authorized Person:

Place: Name of Authorized Person:

Designation of Authorized Person:

Company Name:

Company Seal:



Annexure 2 – Turnover Statement[To be prepared on letterhead of Chartered Accountant.

Scanned copy of original should be uploaded]IFE No.: __________________________ Date: __/__/2015

To,


The Annual Turnover of M/s. ____________________________________ for the last three financial years, viz, 2011-12, 2012-13 and 2013-14, are given below and certified that the statement is true and correct.Sl.No. Financial Year Turnover (in Rs.)

1. Financial Year 2011-2012



Date: Signature of Chartered Accountant:

Place: Name of Chartered Accountant:

Seal of Chartered Accountant:

Registration Number of Chartered Accountant:



Annexure 3 – Affidavit Format[To be submitted by bidder on Rs. 100/- Stamp Paper and should be notarized.]

AFF IDAVITIFE No.: __________________________ Date: __/__/2015

This affidavit is executed by M/s ____________________________________________ on ____ day of _____________ (month) , _______ (year), for the Expression of Interest of Karnataka State Drug Logistics and Warehousing Society, Bangalore, for the EOI for Empanelment of Suppliers for Drugs, Chemicals, Surgicals & Sutures vide reference No. _________________________________.

I / We, hereby declare and undertake on oath as follows:

1) I / We, understand that if I / we, qualify in the EOI, I / we, shall be empanelled for a period of two (2) years, i.e., 2015-16 and 2016-17, which may be extended as desired by the Purchaser.

2) I / We, have gone through all the terms & conditions of the above EOI and here by agree to accept and undertake to abide by the same.

3) I / We, undertake to submit nonrefundable Empanelment Fees in accordance with the terms and conditions of the EOI.

1) I / We, understand that you are not bound to accept any offer / EOI / EOI, you may receive.

2) I / We, accept to abide to affix logogram and barcode as specified by the Purchaser from time to time.

3) I / We, declare that all the documents, testimonials, certificates, etc., submitted by us for the above mentioned EOI are all correct and genuine.

4) I / We, declare that M/s. __________________ is not blacklisted or de-registered by any Government / Quasi Government / and other organization.

5) I / We, declare that I / we, will not supply Not of Standard Quality (NOSQ) Drugs, Chemicals, Surgicals & Sutures.

6) I / We, am / are, aware that if one or more of the above declarations and undertakings are found to have been violated/breached, then I / we, shall be blacklisted by Karnataka State Drug Logistics and Warehousing Society for the period of five years.

Identified by me. Deponent

Advocate:

Name:

Title:

Company:

Date:

Place:



Annexure 4 – Market Standing Certificate[To be certified by Chartered Accountant]

MARKET STANDING CERTIFICATE – [FOR IMPORTERS ONLY]IFE No.: __________________________ Date: __/__/2015

To,


This is to certify that M/s …………………....................................................... has manufactured / imported the following category / form during the years 2011-12, 2012-13 and 2013-14.

Largest Batch Details

Sl.No.

Category / Form

Financial Year

Whether New Drug as per Drugs Act

No. of Batches Imported

Batch Numbers

Name & Address of Purchaser

1. Aqueous solution

2011-12

2012-13

2013-14

4. Capsule

2011-12

2012-13

2013-14

7. Cream

2011-12

2012-13

2013-14

10. Crystals for solution

2011-12

2012-13

2013-14

13. Dispersible Tablet

2011-12

2012-13

2013-14

16. Drops 2011-12

2012-13




Sl.No.

Category / Form

Financial Year



Batch Numbers


2013-14

19. Dusting Powder

2011-12

2012-13

2013-14

22. Ear Drops

2011-12

2012-13

2013-14

25. EC Tablet

2011-12

2012-13

2013-14

28. Elixir

2011-12

2012-13

2013-14

31. Eye/Ear Drops

2011-12

2012-13

2013-14

34. Gel

2011-12

2012-13

2013-14

37. Granules

2011-12

2012-13

2013-14

40. Infusion

2011-12

2012-13

2013-14

43. Inhalation

2011-12

2012-13

2013-14

46. Injection

2011-12

2012-13

2013-14

49. Injection (Powder)

2011-12

2012-13

2013-14




Sl.No.

Category / Form

Financial Year



Batch Numbers


52. Injection in Oil

2011-12

2012-13

2013-14

55. IUD

2011-12

2012-13

2013-14

58. Jelly

2011-12

2012-13

2013-14

61. Liquid

2011-12

2012-13

2013-14

64. Lotion

2011-12

2012-13

2013-14

67. Oily, suspension

2011-12

2012-13

2013-14

70. Ointment

2011-12

2012-13

2013-14

73. Oral

2011-12

2012-13

2013-14

76. Paint

2011-12

2012-13

2013-14

79. Pessaries

2011-12

2012-13

2013-14

82. Powder

2011-12

2012-13

2013-14

2011-12




Sl.No.

Category / Form

Financial Year



Batch Numbers


85. Powder for Infusion

2012-13

2013-14

88. Powder for solution

2011-12

2012-13

2013-14

91. Powder for suspension

2011-12

2012-13

2013-14

94. Solution

2011-12

2012-13

2013-14

97. Spinal Injection

2011-12

2012-13

2013-14

100. Spray

2011-12

2012-13

2013-14

103. Suppository

2011-12

2012-13

2013-14

106. Suspension

2011-12

2012-13

2013-14

109. Syrup

2011-12

2012-13

2013-14

112. Tablet

2011-12

2012-13

2013-14

115. Tincture

2011-12

2012-13

2013-14

118. Topical Form 2011-12

2012-13




Sl.No.

Category / Form

Financial Year



Batch Numbers


2013-14

Date: Signature of Manufacturer:

Place: Name:

Designation:

Company Name:

Company Seal:





Annexure 5 – Performance Certificate[To be issued by Office of the Drug Controller (not below the rank of Additional Drug

Controller)]

PERFORMANCE & NO CONVICTION CERTIFICATE

IFE No.: __________________________ Date: __/__/2015

To,




This is to certify that M/s …………………....................................................... situated at ……………………………............................................... is holding license/s in form/s No .......................... bearing No. ………………………………………. respectively, granted under the provision of Drugs and Cosmetics Act 1940 and Rules thereunder and that their performance for the preceding three financial years, i.e., 2011-12, 2012-13 and 2013-14, has been satisfactory and that:

1) The Drug/s in respect of which this certificate is issued (stated at serial no. 9 below) is / are manufactured / imported on their own license.

2) The manufacturer has their own Quality Control section (Applicable for Indian Manufacturers only).

3) During the preceding three financial years, i.e., 2011-12, 2012-13 & 2013-14, there is no instance of suspension or cancellation of a part / whole of a license issued to the manufacturer / importer, in respect of the Drug/s which is / are offered by the manufacturer / importer in the EOI on account of Drugs (stated at serial no. 9 below) being “Not of Standard Quality” or adulterated or spurious.

4) During the preceding three financial years, i.e., 2011-12, 2012-13 & 2013-14, there is no instance of suspension or cancellation of license/s or a part thereof for violation of conditions of the license/s granted.

5) No administrative action or prosecution is contemplated or launched against the manufacturer / importer under the Drugs and Cosmetics Act, 1940 and Rules thereunder in respect of Drugs offered by them.

6) We here by certify that the above said manufacturer / Importer has not been convicted for violation of provisions of Drugs & Cosmetics Act 1940 & Rules thereunder during the preceding three financial years, i.e., during 2011-12, 2012-13 & 2013-14.

7) We here by certify that the above said manufacturer uses F.F.S. (the whole operation of Form, Filling & Sealing occur simultaneously on the same machine in single cycle) Technology in the manufacturing of the preparations.

8) This certificate is issued for the purpose of participation in the EOI for empanelment of Drugs, Chemicals, Surgicals & Sutures to the Additional Director, Karnataka State Drugs Logistics & Warehousing Society, Government of Karnataka, for the years 2015-16 and 2016-17 for the following list of drugs and items:

Sl.No. Sl.No. of EOI

Name of Drug / Item Dosage Form Strength / Size

1.

2.

3.

4.

5.

6.

7.



8.

9.

10.

11.

12.

13.

14.

15.

Date:Signature of

Certifying Authority:

Place: Seal:



Annexure 6 – Manufacturing Facility Details[To be certified by Chartered Accountant]

MANUFACTURING FACILITY DETAILSIFE No.: __________________________ Date: __/__/2015

1) Manufacturer Details:Sl. Particulars Details

a) Company Name

b) Registered Address

c) Phone

d) Fax

e) Email

f) Authorized Signatory for this EOI

g) Authorized Signatory Contact Details

2) Manufacturing Unit Details:Sl. Particulars Details

a) Address

b) Phone

c) Fax

d) Factory Head – Name

e) Factory Head - Designation

f) Date of Inception

g) License No. & Date

h) License Issuing Authority

i) License Valid Up to



3) Installed Capacity & Production Details:Installed Capacity Actual Production

Sl.No. Category / Form No. of Units /Shift

No. of Shifts / Day

No. of Units / Year

FY 2011-12

FY 2012-13

FY 2013-14

1. Aqueous solution

2. Capsule

3. Cream

4. Crystals for solution

5. Dispersible Tablet

6. Drops

7. Dusting Powder

8. Ear Drops

9. EC Tablet

10. Elixir

11. Eye/Ear Drops

12. Gel

13. Granules

14. Infusion

15. Inhalation

16. Injection

17. Injection (Powder)

18. Injection in Oil

19. IUD

20. Jelly

21. Liquid

22. Lotion

23. Oily, suspension

24. Ointment

25. Oral

26. Paint

27. Pessaries

28. Powder

29. Powder for Infusion



Installed Capacity Actual Production

Sl.No. Category / Form No. of Units /Shift

No. of Shifts / Day

No. of Units / Year

FY 2011-12

FY 2012-13

FY 2013-14

30. Powder for solution

31. Powder for suspension

32. Solution

33. Spinal Injection

34. Spray

35. Suppository

36. Suspension

37. Syrup

38. Tablet

39. Tincture

40. Topical Form

4) Quality Control Details:

a) Good Manufacturing Practices (GMP) adopted for the Manufacturing Process:

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.



b) Quality Certifications available for Manufacturing Process:

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

Date: Signature of Manufacturer:

Place: Name:

Designation:

Seal of Manufacturer:







Annexure 7 – Sample Submission Format[To be duly filled and submitted along with the samples]

SAMPLE SUBMISSION FOR INSPECTIONIFE No.: __________________________ Date: __/__/2015

To,

Additional Director, Karnataka State Drug Logistic and Ware Housing Society, Siddaiah Puranik Road, Bangalore – 560 079Sl.No. Sl.No. in

EOIName of Drug / Item

Dosage Form

Strength / Size

Unit Pack Quantity

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

Total Samples Submitted

Date: Signature of Manufacturer:Place: Name:

Designation:Company Name:

Company Seal:ACKNOWLEDGEMENT

IFE No.: __________________________ Date: __/__/2015

This office is in receipt of a total of ________ number of samples from M/s _______________________________________________________ for the above said EOI.

Date: Signature:

[Duplicate copy of this document after sample submission will be returned as acknowledgement]



Quantity of Samples to be submittedSl.No. Category / Form Quantity of Samples to be

Submitted

1. Vials 1 unit

2. Tabs/Caps 1x10x10

3. Powders, etc. 1 unit

4. Cotton Rolls / Bandage Cloth 1 unit

5. IV Infusions including Antibacterial and Antibiotic infusions

1 unit

6. Ointment Tubes 1 unit

7. Ampoules 1 unit

8. Liquids in bottles with PP caps 1 unit

9. Disinfectants Suitable Pack size with complete packing details

10. Any form / category not covered above 1 unit



Annexure 8 – List of Drugs & Items Submitted for Empanelment

LIST OF DRUGS & ITEMS SUBMITTEDED FOR EMPANELMENT

[Bidders should duly fill the drugs & items in the Excel format provided in the e-procurement portal only and upload the dully filled Excel along with the EOI before

the EOI submission date]

END OF DOCUMENT


Date post:	24-May-2018
Category:	Documents
Upload:	vanque
View:	214 times
Download:	1 times